R. Holland
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Isabel AmendoeiraLawrence von KarsaChris de WolfNick PerryM. BroedersJ.L. PeterseIS FentimanJ.A. van Dongen
- Topics
- Breast Cancer Treatment Studies (5 papers)Breast Lesions and Carcinomas (4 papers)Radiomics and Machine Learning in Medical Imaging (1 paper)
- Partner nations
- NetherlandsUnited StatesSweden
In The Last Decade
R. Holland
13 papers receiving 924 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 413
- Radiology, Nuclear Medicine and Imaging 307
- Cancer Research 307
- Pulmonary and Respiratory Medicine 290
- Pathology and Forensic Medicine 284
Countries citing papers authored by R. Holland
This map shows the geographic impact of R. Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Holland more than expected).
Fields of papers citing papers by R. Holland
This network shows the impact of papers produced by R. Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Holland. The network helps show where R. Holland may publish in the future.
Co-authorship network of co-authors of R. Holland
This figure shows the co-authorship network connecting the top 25 collaborators of R. Holland. A scholar is included among the top collaborators of R. Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Holland. R. Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | European guidelines for quality assurance in breast cancer screening and diagnosisbreakdown → | 611 |
| 2 | 33 | |
| 3 | [Diagnostics in clinically occult, radiologically suspect breast lesions more often surgery than needle diagnostics with image monitoring]. | 1 |
| 4 | 119 | |
| 5 | 2 | |
| 6 | 89 | |
| 7 | 53 | |
| 8 | 12 | |
| 9 | The role of specimen x-ray in the diagnosis of breast cancer. | 13 |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 8 | |
| 13 | 21 | |
| 14 | 2 |
About R. Holland
R. Holland is a scholar working on Cancer Research, Pathology and Forensic Medicine and Periodontics, having authored 14 papers that have together received 967 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (4 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Cancer Research (307 citations), Pathology and Forensic Medicine (284 citations) and Oncology (413 citations). R. Holland has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include Isabel Amendoeira, Lawrence von Karsa, Chris de Wolf, Nick Perry, M. Broeders, J.L. Peterse, IS Fentiman, J.A. van Dongen, Michael D. Lagios and R R Millis. Their work appears in journals such as The Lancet, Radiology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.